Hematopoietic stem cell allografts using a non-myeloablative conditioning regimen can be safely performed on an outpatient basis: Report of four cases

Bone Marrow Transplantation

Volumn 25, Issue 2, 2000, Pages 131-133

  Gomez Almaguer D ^a   Ruiz Arguelles G J ^b,c   Ruiz Arguelles A ^c   Gonzalez Llano O ^a   Cantu O E ^a   Hernandez N E ^a  

^a HOSPITAL UNIVERSITARIO DR JOSÉ ELEUTERIO GONZÁLEZ   (Mexico)

^b CENTRO DE HEMATOLOGÍA Y MEDICINA INTERNA DE PUEBLA   (Mexico)

^c Laboratorios Clinicos de Puebla   (Mexico)

Author keywords

Allogeneic; BMT; Non myeloablative; Outpatient

Indexed keywords

ALKANESULFONIC ACID DERIVATIVE; BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; FLUDARABINE; FOLIC ACID ANTAGONIST; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; PURINE ANTAGONIST;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; CASE REPORT; CHRONIC MYELOID LEUKEMIA; FEMALE; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; MALE; NEUTROPHIL; OUTPATIENT; PRIORITY JOURNAL; RASH; THALASSEMIA MAJOR; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA;

EID: 0342614933     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1702100     Document Type: Article

References (17)

1. Negrin R, Storb R, Forman S. Bone marrow transplantation in malignant disease. In: McArthur JR, Schechter GP, Schrier SL (eds). Hematology 1998. The American Society of Hematology Education Program Book: Washington, 1998, pp 342-370.
2. Giralt S, Estey E, Albitar M et al. Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: harnessing graft-versus-leukemia without myeoablative therapy. Blood 1997; 89: 4331-4336.
3. Slavin S, Nagler A, Naparstek E et al. Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematological diseases. Blood 1998; 91: 756-763.
4. Khouri IF, Keating M, Korbling M et al. Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies. J Clin Oncol 1998; 16: 2817-2824.
5. Ruiz-Argüelles GJ, Ruiz-Argüelles A, Pérez-Romano B et al. Filgrastim-mobilized peripheral-blood stem cells can be stored at 4 degrees and used in autografts to rescue high-dose chemotherapy. Am J Hematol 1995; 48: 100-103.
6. Gómez-Almaguer D, Ruiz-Argüelles GJ, Ruiz-Argüelles A, Piñeiro LA. Dos casos de trasplante heterólogo con sangre periférica. Rev Invest Clin Méx 1997; 49: 41-45.
7. Ruiz-Argüelles GJ, Ruiz-Argüelles A, Pérez-Romano B et al. Non-cryopreserved peripheral blood stem cells autotransplants for hematological malignancies can be performed entirely on an outpatient basis. Am J Hematol 1998; 58: 161-164.
8. Kessinger A, Armitage JO, Landmark JD et al. Autologous peripheral hematopoietic stem cell transplantation restores hemopoietic function following marrow ablative therapy. Blood 1998; 71: 723-727.
9. Ruiz-Argüelles A. Flow cytometry in the clinical laboratory. Principles, applications and problems. Ann Biol Clin 1992; 50: 735-743.
10. Ruiz-Argüelles A, Orfao A. Caracterización y evaluación de células totipotenciales en sangre periférica y médula ósea. In: Ruiz-Argüelles GJ, San-Miguel JF (eds). Actualización en Leucemias. Editorial Médica Panamericana: Mexico City, 1996, pp 79-82.
11. Pinkel D, Straume T, Gray JW. Citogenetic analysis using quantitative, high sensitivity fluorescence hybridization. Proc Natl Acad Sci USA 1996; 83: 2934-2938.
12. Armitage JO. Bone marrow transplantation. New Engl J Med 1994; 330: 827-838.
13. Thomas ED. Hematopoietic stem cell transplantation. Sci Am 1995; 272: 38-47.
14. Ruiz-Argüelles GJ, Bruno GV. Trasplante de células totipotenciales hematopoyéticas. In: Castellanos-Coutiño J (ed). Temas de Medicina Interna: Transplante de órganos. Asociación de Medicina Interna de México. McGraw Hill/ Interamericana: México City, 1998, pp 85-99.
15. Vesole DH, Tricot G, Jagannath S, et al. Autotransplants in multiple myeloma: what have we learned? Blood 1996; 88: 838-847.
16. Ruiz-Argüelles GJ, Apreza-Molina MG, Alemán-Hoey DD et al. Outpatient supportive therapy after induction to remission therapy in adult acute myelogenous leukaemia (AML) is feasible: a multicentre study. Eur J Haematol 1995; 54: 18-20.
17. Ruiz-Argüelles GJ, Lobato-Mendizábal E, Delgado-Lamas JL, Gómez-Almaguer D. All trans-retinoic acid decreases early mortality in patients with promyelocytic leukemia and can be given entirely on an outpatient basis. Am J Hematol 1999; 62: 139-143.